ID   TU-MM-1
AC   CVCL_1G72
SY   Tottori University-Malignant Mesothelioma-1
DR   cancercelllines; CVCL_1G72
DR   Cosmic; 2758997
DR   Wikidata; Q54973327
RX   PubMed=26070481;
CC   Population: Japanese.
CC   Doubling time: 67.9 hours (PubMed=26070481).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=26070481).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Val1822Asp (c.5465T>A) (V1804D); ClinVar=VCV000021030; Zygosity=Unspecified (PubMed=26070481).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Unspecified (PubMed=26070481).
CC   Omics: Deep exome analysis.
CC   Omics: Genome sequenced.
CC   Derived from site: In situ; Peritoneum; UBERON=UBERON_0002358.
DI   NCIt; C9350; Peritoneal malignant mesothelioma
DI   ORDO; Orphanet_168811; Malignant peritoneal mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 18
//
RX   PubMed=26070481; DOI=10.1007/s13577-015-0120-8;
RA   Oumi N., Itamochi H., Komatsu H., Oishi T., Shimada M., Sato S.,
RA   Chikumi J., Sato S., Nonaka M., Kudoh A., Harada T.;
RT   "Establishment and mutation analysis of a novel malignant peritoneal
RT   mesothelioma cell line, TU-MM-1, using whole genome sequencing.";
RL   Hum. Cell 29:46-51(2016).
//